Jonathan Paul

@TheRealDoctorOs You should be ahsamed of yourself

Do you tip your uber driver? 🚕

PE risk stratification shouldn’t depend on who’s on call. Yet across PERT teams, the same patient can get labeled differently. We built something to fix that: pecompass.org

Presented at #ACC26: In patients with pulmonary embolism, ultrasound-facilitated, catheter-directed fibrinolysis led to a lower risk of a composite of major adverse outcomes than anticoagulation alone. Full HI-PEITHO trial results: nejm.org/doi/full/10.10… Editorial: Advanced Therapy for Intermediate-Risk Pulmonary Embolism nejm.org/doi/full/10.10… @ACCinTouch

📣 Hot Take Alert 🚨 : Lytics were never dead, industry just lied to you 😵‍💫 #irad prnewswire.com/news-releases/…

First time seeing this! Single coronary artery anatomy from the right coronary ostium. Hope they don’t have a STEMI!

It’s a week of hope and dreams. Baseball is back!

@frank_medina_ @NU_IntMed @UChiPritzker Congrats Frank! Glad to keep you in Chicago!

I don’t have the words to accurately describe the gratitude I feel to continue my medical training at @NU_IntMed. I wouldn’t be here without the love and sacrifice of my parents. Neither graduated college and now they’ll have a soon-tobe doctor as a son. Thank you @UChiPritzker

If you are confused about advanced therapy recommendations for acute PE in the recent @ACCinTouch @AHAScience Multidisciplinary PE guidelines, strongly recommend referring to this figure. Reminder that although catheter-based interventions have the strongest recommendation for the highest acuity PE patients, the @PERTConsortium PERT Team framework is recommended to assist with determining treatment for lower acuity patients and should still be considered. This rec will likely be updated with upcoming RCTs. Great work @criticalecho and colleagues. jacc.org/doi/10.1016/j.…

Wow

@jaygirimd @JayMathewsMD @ISeropianMD @GBarnesMD @drandrewsharp @jameshorowitzmd @DrJayMohan @roblookstein Can you clarify how the respiratory modifier is meant to influence management? Does it bump you up a category/subcategory?

@JayMathewsMD @ISeropianMD @GBarnesMD @drandrewsharp @jameshorowitzmd @DrJayMohan @roblookstein PE TRACT only one of 5 advanced therapies enrolling C2 and up. All the others are C3 and up. Expect updates to this section after 5 trials published.

I need som help w this table All trials for MT/CDL (except FLAME and few pts in SEATLEII) were in C2-D2 pts. Yet stronger (2a) recomm for CDL/MT is in E. .. that were excluded from trials. Thougts @jaygirimd @GBarnesMD @drandrewsharp @jameshorowitzmd @DrJayMohan @roblookstein

Excellent summary! Thanks @jaygirimd !

@seanw_m This gives me anxiety

MUH TRADITIONAL ARCHITECTURE

@NMCardioVasc @SchimmelHeart Congrats Dan and team!

Congratulations to Daniel R. Schimmel, MD, (@SchimmelHeart) cardiologist and medical director of the Cardiac Catheterization Lab, and the Cath Lab team on becoming the first COSIRA II clinical trial enrolling site in the Chicago area. The clinical trial is evaluating a novel therapy for patients with refractory, chronic angina. Innovative trials like this are just one way we’re advancing evidence-based cardiovascular care and clinical research.

@TheRealDoctorOs Kneejoint bloodtube

Name that artery… 👀 #irad

📣 #ACC26 Late-Breaking Clinical Trials Announced! Learn the results of HI-PEITHO, CHAMPION-AF, VESALIUS-CV & many more as presenters discuss & debate the research & innovations shaping the future of cardiovascular care. Find out more & register today ➡️ bit.ly/4bJf0Oc

@SandeepNathanMD @UChicagoMed @amgbonaguro @zghouzi @UCCardsFellows @UChicagoCardio @uchicagohvc @JKhambhati @adamvohra @TeekMD @PWard35 @JSlivnickMD @ValJeevanandam Welcome to you both! Excited to have you join the team

Please join me in welcoming our incoming @UChicagoMed #InterventionalCardiology fellows, @amgbonaguro & @zghouzi who will be joining us July 2026. On behalf of my partners, colleagues & the entire #UChicagoCathLab family, congratulations & welcome! #CardioTwitter #CardioX

@TheRealDoctorOs KFC: Kerala Fried Chicken

Best 🇮🇳 chicken 🐓

@CocoSejo @RSteinbergMD @catweneboah @ChiHForum @CardioNerds I ❤️ Hemodynamics!

@Jonathan_PaulMD provides a fantastic talk on HD changes seen in acute PE. 🗝️ Intermediate risk patients are sicker than you may think. 🗝️ Metrics for risk: PESI, RV/LV ratio, TTE. All imperfect. 🗝️ Hemodynamics can help stratify risk! #ChiHemos2025

A lung and a tree

@adamcifu Beauty! Ancient plant!

And, for a break from medicine, one of ginkgos I am raising from nut.